等待開盤 09-20 09:30:00 美东时间
+0.025
+6.85%
Clinical Advisory Board to Provide Strategy for Advancing Preclinical Oncology Program in Mesothelioma AUSTIN, Texas, Sept. 19, 2024 /PRNewswire/ -- Genprex, Inc. ("Genprex" or the "Company"...
09-19 21:29
Genprex Releases New Video Featuring Chief Medical Officer Discussing Positive ...
08-15 21:30
北京时间2024年08月15日02时48分,塞德斯医疗(CLDX.us)股票出现异动,股价快速下跌5.02%。截至发稿,该股报31.61美元/股,成交量19....
08-15 02:48
Genprex (NASDAQ:GNPX) shares slid 14% Wednesday after the biotech company said it was discontinuing its Acclaim-2 Phase 1/2 study for its gene therapy Reqorsa due in part to enrollment issues. The Acc...
08-15 02:27
Genprex Inc: Expects to Conduct an Interim Analysis in Phase 2a Expansion of Ac...
08-14 21:28
Genprex Inc: Expects to Start Phase 2 Expansion Portion of Acclaim-3 Study in S...
08-14 21:26
Genprex Announces Positive Clinical Study Updates From Acclaim-1 and Acclaim-3 ...
08-14 21:25
Expands on the previously granted patents covering the use of REQORSA in combination with immune checkpoint inhibitors
08-13 20:33
Genprex Granted Patent in Singapore for Reqorsa® Gene Therapy With Pd-1 Antibod...
08-13 20:31
Genprex Inc : Alliance Global Partners Cuts Target Price to $7.5 From $8
08-13 19:35